HK67983A - 8-substituted-4-amino-3-quinaline-carboxylic acids and esters-antisecretary,anti-ulcer compounds - Google Patents

8-substituted-4-amino-3-quinaline-carboxylic acids and esters-antisecretary,anti-ulcer compounds

Info

Publication number
HK67983A
HK67983A HK679/83A HK67983A HK67983A HK 67983 A HK67983 A HK 67983A HK 679/83 A HK679/83 A HK 679/83A HK 67983 A HK67983 A HK 67983A HK 67983 A HK67983 A HK 67983A
Authority
HK
Hong Kong
Prior art keywords
antisecretary
quinaline
esters
amino
substituted
Prior art date
Application number
HK679/83A
Other languages
English (en)
Inventor
Harry Randall Munson
Reevis Stancil Alphin
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of HK67983A publication Critical patent/HK67983A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK679/83A 1979-03-26 1983-12-15 8-substituted-4-amino-3-quinaline-carboxylic acids and esters-antisecretary,anti-ulcer compounds HK67983A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2398179A 1979-03-26 1979-03-26
US06/127,153 US4343804A (en) 1979-03-26 1980-03-04 4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds

Publications (1)

Publication Number Publication Date
HK67983A true HK67983A (en) 1983-12-23

Family

ID=26697875

Family Applications (1)

Application Number Title Priority Date Filing Date
HK679/83A HK67983A (en) 1979-03-26 1983-12-15 8-substituted-4-amino-3-quinaline-carboxylic acids and esters-antisecretary,anti-ulcer compounds

Country Status (31)

Country Link
US (1) US4343804A (no)
JP (1) JPH02117663A (no)
AR (1) AR230268A1 (no)
AT (1) AT372373B (no)
AU (1) AU528388B2 (no)
BR (1) BR8001779A (no)
CA (1) CA1147338A (no)
CH (1) CH644105A5 (no)
DE (1) DE3011490A1 (no)
DK (1) DK156056C (no)
EG (1) EG15009A (no)
ES (1) ES8103048A1 (no)
FI (1) FI77452C (no)
FR (1) FR2452485B1 (no)
GB (1) GB2047244B (no)
GR (1) GR68006B (no)
HK (1) HK67983A (no)
IE (1) IE49577B1 (no)
IL (1) IL59628A (no)
IN (1) IN151446B (no)
IT (1) IT1133079B (no)
MX (1) MX6264E (no)
NL (1) NL8001752A (no)
NO (1) NO153927C (no)
NZ (1) NZ193252A (no)
PH (1) PH16416A (no)
PL (1) PL125030B1 (no)
PT (1) PT71008B (no)
SE (1) SE435837B (no)
SG (1) SG33683G (no)
YU (1) YU41702B (no)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610981D0 (en) * 1986-05-06 1986-06-11 Ici America Inc Quinoline amides
GB8621425D0 (en) * 1986-09-05 1986-10-15 Smith Kline French Lab Compounds
GB8804447D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804443D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804445D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804444D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804446D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804448D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
US5432182A (en) * 1989-02-23 1995-07-11 Smithkline Beecham Intercredit B.V. Compounds substituted quinoline derivatives
CA2011086A1 (en) * 1989-03-17 1990-09-17 Karl-Heinz Geiss 2-alkyl-4-arylmethylaminoquinolines, the use thereof and drugs prepared therefrom
DE3917233A1 (de) * 1989-05-26 1990-11-29 Basf Ag 8-substituierte 4-(heterocyclylmethylamino)-chinoline, ihre verwendung und daraus hergestellte arzneimittel
GB8918265D0 (en) * 1989-08-10 1989-09-20 Smithkline Beckman Intercredit Compounds
US5362743A (en) * 1993-03-09 1994-11-08 Pfizer Inc. Aminoquinoline derivatives
US5556863A (en) * 1993-06-11 1996-09-17 Astra Aktiebolag Compound for gastric acid secretion inhibition
IS4164A (is) * 1993-06-11 1994-12-12 Ab Astra Efnasambönd sem hindra flæði magasýru
EP0720601B1 (en) * 1993-08-10 2000-10-25 James Black Foundation Limited Gastrin and cck receptor ligands
US5650415A (en) * 1995-06-07 1997-07-22 Sugen, Inc. Quinoline compounds
KR0169813B1 (ko) * 1995-07-12 1999-01-15 김종인 4-아미노-3-아실나프티리딘 유도체
US5760041A (en) * 1996-02-05 1998-06-02 American Cyanamid Company 4-aminoquinazoline EGFR Inhibitors
US6875769B2 (en) * 1996-05-23 2005-04-05 Pfizer Inc. Substituted6,6-hetero-bicyclicderivatives
US5929080A (en) * 1997-05-06 1999-07-27 American Cyanamid Company Method of treating polycystic kidney disease
US6251912B1 (en) 1997-08-01 2001-06-26 American Cyanamid Company Substituted quinazoline derivatives
US6323209B1 (en) 1997-11-06 2001-11-27 American Cyanamid Company Method of treating or inhibiting colonic polyps
ES2457396T3 (es) 1998-09-29 2014-04-25 Wyeth Holdings Llc 3-Cianoquinolinas sustituidas como inhibidores de las proteínas tirosina quinasas
HUP0203973A3 (en) * 1999-12-28 2004-07-28 Eisai Co Ltd Heterocyclic compounds having sulfonamide groups, pharmaceutical compositions containing them and their use
US6521618B2 (en) 2000-03-28 2003-02-18 Wyeth 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
US6576644B2 (en) * 2000-09-06 2003-06-10 Bristol-Myers Squibb Co. Quinoline inhibitors of cGMP phosphodiesterase
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
GEP20084540B (en) 2003-01-14 2008-11-25 Arena Pharm Inc 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
ME00524B (me) 2003-03-10 2011-10-10 Astrazeneca Ab Novi postupak za dobijanje roflumilasta
TWI335328B (en) * 2003-07-14 2011-01-01 Arena Pharm Inc Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related hereto
WO2006097456A1 (en) * 2005-03-16 2006-09-21 Nycomed Gmbh Taste masked dosage form containing roflumilast
WO2011022216A1 (en) * 2009-08-17 2011-02-24 High Point Pharmaceuticals, Llc Substituted pyridine derivatives, pharmaceutical compositions, and methods of use to treat oxidative stress
CN103221391B (zh) 2010-01-27 2018-07-06 艾尼纳制药公司 (R)-2-(7-(4-环戊基-3-(三氟甲基)苄基氧基)-1,2,3,4-四氢环戊二烯并[b]吲哚-3-基)乙酸及其盐的制备方法
CA2812061A1 (en) 2010-09-22 2012-03-29 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
AU2016205361C1 (en) 2015-01-06 2021-04-08 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the S1P1 receptor
KR102603199B1 (ko) 2015-06-22 2023-11-16 아레나 파마슈티칼스, 인크. Ｓ1ｐ1 수용체-관련 장애에서의 사용을 위한 (ｒ)-2-(7-(4-시클로펜틸-3-(트리플루오로메틸)벤질옥시)-1,2,3,4-테트라히드로시클로-펜타[ｂ]인돌-3-일)아세트산 (화합물 1)의 결정성 ｌ-아르기닌 염
UA126119C2 (uk) * 2016-11-11 2022-08-17 Баєр Енімал Хелс Гмбх Протигельмінтні похідні хінолін-3-карбоксаміду
MX2019009841A (es) 2017-02-16 2020-01-30 Arena Pharm Inc Compuestos y metodos para el tratamiento de la colangitis biliar primaria.
US20210177827A1 (en) * 2017-10-25 2021-06-17 Children`S Medical Center Corporation Papd5 inhibitors and methods of use thereof
SG11202010024UA (en) 2018-05-09 2020-11-27 Bayer Animal Health Gmbh New quinoline derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470186A (en) * 1967-06-02 1969-09-30 American Cyanamid Co Substituted 4-anilino-3-quinolinecarboxylic acids and esters
JPS4838712A (no) * 1971-09-18 1973-06-07

Also Published As

Publication number Publication date
CA1147338A (en) 1983-05-31
NO153927C (no) 1986-06-18
US4343804A (en) 1982-08-10
ES489887A0 (es) 1981-02-16
IT1133079B (it) 1986-07-09
FR2452485B1 (fr) 1986-09-12
JPH02117663A (ja) 1990-05-02
DE3011490A1 (de) 1981-03-12
GB2047244B (en) 1983-02-23
FR2452485A1 (fr) 1980-10-24
IL59628A0 (en) 1980-06-30
FI77452B (fi) 1988-11-30
GR68006B (no) 1981-10-26
PL125030B1 (en) 1983-03-31
CH644105A5 (fr) 1984-07-13
MX6264E (es) 1985-02-19
SE8002292L (sv) 1980-09-27
PL222993A1 (no) 1981-01-30
DK156056B (da) 1989-06-19
PT71008A (en) 1980-04-01
PH16416A (en) 1983-09-29
IL59628A (en) 1983-06-15
FI800910A (fi) 1980-09-27
IE800605L (en) 1980-09-26
IT8067465A0 (it) 1980-03-26
YU84480A (en) 1983-10-31
EG15009A (en) 1985-03-31
YU41702B (en) 1987-12-31
FI77452C (fi) 1989-03-10
NL8001752A (nl) 1980-09-30
BR8001779A (pt) 1980-11-18
PT71008B (en) 1981-06-25
NO153927B (no) 1986-03-10
DE3011490C2 (no) 1988-12-22
NZ193252A (en) 1984-04-27
IE49577B1 (en) 1985-10-30
NO800858L (no) 1980-09-29
SG33683G (en) 1985-03-29
ES8103048A1 (es) 1981-02-16
GB2047244A (en) 1980-11-26
IN151446B (no) 1983-04-23
AU528388B2 (en) 1983-04-28
AT372373B (de) 1983-09-26
AR230268A1 (es) 1984-03-01
AU5684880A (en) 1980-10-02
DK128380A (da) 1980-09-27
ATA156480A (de) 1983-02-15
SE435837B (sv) 1984-10-22
DK156056C (da) 1989-11-06

Similar Documents

Publication Publication Date Title
PH16416A (en) 4-amino-3-quinolinecarboxylic acids and esters-antisecretory,anti-ulcer compounds
GB2042535B (en) 1-acylated-1,2,3,4-tetrahydroquinoline-2-carboxylic acids
GB2064520B (en) A-aryl-1h-1,2,4-triazole-1-ethanols
IL60272A0 (en) 7 and 7-8 substituted 4,5 -epoxymorphinan-6-one compounds
IL59829A0 (en) Substituted 9,10-anthracene-bishydrazones
AU521533B2 (en) 1, 2-benzisoxazolozyacetic acids and related compounds
GB2044770B (en) 24,24 - difluoro- 25 - hydroxycholecalciferol
NZ193666A (en) 3-aryl-2-(2,3-dihydrothiazol-2-ylidene)-3-oxopropionitriles
CS409780A1 (en) Zpusob kontinualniho valcovani i profilu
AU9007482A (en) Quilting
GB2043812B (en) Glanded connection
ZA801526B (en) 4-amino-3-quinolinecarboxylic acids and esters-antisecretory, anti-ulcer compounds
JPS5671212A (en) Superconductor
PH16875A (en) Pyridylaminotriazole anti-ulcer agents
GB2075982B (en) 1-3-dihydroxy-27-nor-cholesta-5-en and 5,7-dien-25-one
IL75705A (en) 1,2,5-thiadiazole-1-oxides
ZA804183B (en) 1,2,4-thiadiazolyloxyphenylureas
JPS5687533A (en) Pyrethroid
JPS5667113A (en) Superconductor
JPS5611808A (en) Superconductor
GB2118169B (en) 1,1,1-trichlorotriacontane
JPS55145647A (en) Alphaahalomethylamino acids
JPS55100607A (en) Superconductor
GB2043811B (en) Glanded connection
GB2055832B (en) 1,3,4-thiadiazol-2-yl-4-hydroxy-1-methyl-2-imidaxolidinones